Intelligence Platform
Patents
Browse 61 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10806781
Compositions and methods for live, attenuated alphavirus formulations
granted patentUS 10792353
Virus like particle purification
granted patentUS 10688174
Method of conferring a protective immune response to norovirus
granted patentUS 10675341
Parenteral norovirus vaccine formulations
granted patentUS 10632184
Compositions and methods for stabilizing alphaviruses with improved formulations
granted patentUS 10525120
Methods and compositions for live attenuated viruses
granted patentUS 10512682
Norovirus vaccine formulations
granted patentUS 10501500
Methods of detection and removal of rhabdoviruses from cell lines
granted patentUS 10233429
Hand, foot, and mouth vaccines and methods of manufacture and use thereof
granted patentUS 10172930
Virus like particle purification
granted patentUS 10167320
Purification of virus like particles
granted patentUS 10137186
Compositions and methods for live, attenuated alphavirus formulations
granted patentUS 10130696
Method of conferring a protective immune response to norovirus
granted patentUS 10010599
Norovirus vaccine formulations
granted patentUS 10010600
Compositions and methods for administration of vaccines against dengue virus
granted patentUS 9890362
Compositions, methods and uses for inducing viral growth
granted patentUS 9878031
Compositions, methods of administration and uses for trivalent dengue virus formulations
granted patentUS 9867876
Parenteral norovirus vaccine formulations
granted patentUS 9861691
Norovirus vaccine formulations
granted patentUS 9834757
Hand, foot, and mouth vaccines and methods of manufacture and use thereof
granted patentUS 9821049
Method of conferring a protective immune response to Norovirus
granted patentUS 9801934
Parenteral norovirus vaccine formulations
granted patentUS 9713638
Compositions and methods for rapid immunization against dengue virus
granted patentUS 9518096
Virus-like particles comprising composite capsid amino acid sequences for enhanced cross r
granted